Edition:
United States

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

21.15USD
4:00pm EDT
Change (% chg)

$-0.57 (-2.62%)
Prev Close
$21.72
Open
$22.29
Day's High
$22.45
Day's Low
$19.62
Volume
75,655
Avg. Vol
16,629
52-wk High
$22.45
52-wk Low
$6.66

Chart for

About

KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The Company has developed a portfolio of small molecule plasma kallikrein... (more)

Overall

Beta: 3.08
Market Cap(Mil.): $373.14
Shares Outstanding(Mil.): 17.18
Dividend: --
Yield (%): --

Financials

  KALV.OQ Industry Sector
P/E (TTM): -- 30.48 32.69
EPS (TTM): -1.51 -- --
ROI: -51.59 13.04 12.72
ROE: -60.04 14.99 14.85

Earnings vs. Estimates